Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?

Adverse Events of Intravesical Onabotulinum Toxin A Injection between Patients with Overactive Bladder and Interstitial Cystitis—Different Mechanisms of Action of Botox on Bladder Dysfunction?

Intravesical onabotulinumtoxinA (BoNT-A) injections have been proposed to treat both overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS) in patients with refractory conditions. We compared adverse events (AEs) after BoNT-A treatment between IC/BPS and OAB in women. IC/B...

Full description

Bibliographic Details
Main Authors: Yuh-Chen Kuo, Hann-Chorng Kuo
Format: Article
Language:English
Published: MDPI AG 2016-03-01
Series:Toxins
Subjects:
onabotulinumtoxinA
adverse events
interstitial cystitis
overactive bladder
Online Access:http://www.mdpi.com/2072-6651/8/3/75

Similar Items

Similar Items